XML 113 R7.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Cash flows from operating activities      
Net loss $ (874,366) $ (1,130,535) $ (493,927)
Adjustments to reconcile net loss to net cash flow from operating activities:      
Depreciation and amortization 440,221 486,530 547,990
Loss on impairment 615,294 802,133 121,639
(Gain) loss on extinguishment of debt, net (30,616) 1,793 0
Deferred income taxes (17,825) (68,416) 241,326
Amortization of share-based compensation 14,737 23,993 29,115
Other long-term asset write-off 0 0 29,032
Other costs, net 60,259 6,446 12,590
Changes in components of working capital      
Change in taxes receivable (11,225) 84,847 (49,865)
Net changes in other operating assets and liabilities (9,708) (34,940) (21,225)
Net cash provided by operating activities 186,771 171,851 416,675
Cash flows from investing activities      
Capital expenditures (268,783) (194,779) (120,707)
Proceeds from disposal of assets 12,753 5,402 2,382
Net cash used in investing activities (256,030) (189,377) (118,325)
Cash flows from financing activities      
Issuance of senior notes 0 750,000 0
Borrowings on credit facilities 755,000 0 0
Repayments of credit facilities (420,000) 0 0
Repayments of senior notes (400,000) (972,708) (300,000)
Debt issuance costs (1,092) (15,639) (42)
Purchase of noncontrolling interests (106,744) 0 0
Dividends paid to noncontrolling interests (25,109) (27,579) (56,881)
Taxes withheld on employee stock transactions (2,779) (3,470) (4,320)
Net cash used in financing activities (200,724) (269,396) (361,243)
Net increase (decrease) in cash, cash equivalents and restricted cash (269,983) (286,922) (62,893)
Cash, cash equivalents and restricted cash, beginning of period 375,907 662,829 725,722
Cash, cash equivalents and restricted cash, end of period 105,924 375,907 662,829
Noble Corp      
Cash flows from operating activities      
Net loss (734,904) (1,089,970) (451,732)
Adjustments to reconcile net loss to net cash flow from operating activities:      
Depreciation and amortization 437,690 482,660 543,119
Loss on impairment 615,294 802,133 121,639
(Gain) loss on extinguishment of debt, net (30,616) 1,793 0
Deferred income taxes (17,825) (68,416) 241,326
Amortization of share-based compensation 14,689 23,945 29,046
Other long-term asset write-off 0 0 29,030
Other costs, net (39,741) 6,446 12,591
Changes in components of working capital      
Change in taxes receivable (11,225) 84,847 (49,865)
Net changes in other operating assets and liabilities (6,456) (30,679) (20,080)
Net cash provided by operating activities 226,906 212,759 455,074
Cash flows from investing activities      
Capital expenditures (268,783) (194,779) (120,707)
Proceeds from disposal of assets 12,753 5,402 2,382
Net cash used in investing activities (256,030) (189,377) (118,325)
Cash flows from financing activities      
Issuance of senior notes 0 750,000 0
Borrowings on credit facilities 755,000 0 0
Repayments of credit facilities (420,000) 0 0
Repayments of senior notes (400,000) (972,708) (300,000)
Debt issuance costs (1,092) (15,639) (42)
Purchase of noncontrolling interests (106,744) 0 0
Dividends paid to noncontrolling interests (25,109) (27,579) (56,881)
Contributions (distributions) from (to) parent company, net (42,103) (44,417) 28,352
Net cash used in financing activities (240,048) (310,343) (328,571)
Net increase (decrease) in cash, cash equivalents and restricted cash (269,172) (286,961) 8,178
Cash, cash equivalents and restricted cash, beginning of period 375,050 662,011 653,833
Cash, cash equivalents and restricted cash, end of period $ 105,878 $ 375,050 $ 662,011